Lucent Diagnostics and Tempus integrate blood-based Alzheimer's biomarker testing into clinical workflows
Longevity Tech Radar: FDA-Cleared AI, Biomarkers, and Preventive Diagnostics
This week's radar covers blood-based Alzheimer's biomarkers, FDA-cleared imaging AI, DXA/DEXA upgrades, wearable VO₂ estimates, and smarter questions for buyers.